Alvotech (ALVO) Debt Ratio (2020 - 2026)
Alvotech's (ALVO) quarterly Debt Ratio came in at 0.85 in Q2 2026, little changed on a YoY basis from 0.85 in Q2 2025, and down 9.58% quarter-over-quarter from 0.94 in Q1 2026.
Analysis
Alvotech (ALVO) Debt Ratio (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Debt Ratio for 7 consecutive years, with 0.85 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Debt Ratio changed 0.12% year-over-year to 0.85; the trailing twelve-month figure through Jun 2026 stood at 0.85 (changed 0.12% YoY), and the FY2025 full-year result was 0.91, down 13.1% from the prior year.
- Debt Ratio slipped to 0.85 in Q2 2026 per ALVO's latest filing, from 0.94 in the prior quarter.
- Across five years, Debt Ratio topped out at 1.56 in Q4 2023 and bottomed at 0.85 in Q2 2026.
- Historically, Debt Ratio has averaged 1.05 across 5 years, with a median of 0.98 in 2024.
- The sharpest annual moves came in 2022 and 2024: Debt Ratio surged 106.05% in 2022, then plunged 32.82% in 2024.
- Over 5 years, Debt Ratio stood at 1.38 in 2022, then climbed by 12.78% to 1.56 in 2023, then plunged by 32.82% to 1.05 in 2024, then decreased by 13.1% to 0.91 in 2025, then decreased by 6.9% to 0.85 in 2026.
- According to Business Quant data, Debt Ratio over the past three periods registered 0.85, 0.94, and 0.91 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 0.42 |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 0.38 |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 0.13 |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 0.71 |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 0.87 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 0.85 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 0.20 |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 0.35 |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.85 |
| Mar 31, 2026 | 0.94 |
| Dec 31, 2025 | 0.91 |
| Sep 30, 2025 | 0.95 |
| Jun 30, 2025 | 0.85 |
| Mar 31, 2025 | 1.05 |
| Dec 31, 2024 | 1.05 |
| Sep 30, 2024 | 0.98 |
| Jun 30, 2024 | 1.18 |
| Mar 31, 2024 | 1.23 |
| Dec 31, 2023 | 1.56 |
| Jun 30, 2023 | 0.86 |
| Dec 31, 2022 | 1.38 |
| Jun 30, 2022 | 0.98 |
| Dec 31, 2021 | 0.67 |
| Dec 31, 2020 | 2.32 |